mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for VDR
Gene summary
Basic gene Info.Gene symbolVDR
Gene namevitamin D (1,25- dihydroxyvitamin D3) receptor
SynonymsNR1I1|PPP1R163
CytomapUCSC genome browser: 12q13.11
Type of geneprotein-coding
RefGenesNM_000376.2,
NM_001017535.1,NM_001017536.1,
Description1,25-dihydroxyvitamin D3 receptornuclear receptor subfamily 1 group I member 1protein phosphatase 1, regulatory subunit 163vitamin D nuclear receptor variant 1vitamin D3 receptor
Modification date20141222
dbXrefs MIM : 601769
HGNC : HGNC
Ensembl : ENSG00000111424
HPRD : 03463
Vega : OTTHUMG00000169890
ProteinUniProt: P11473
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_VDR
BioGPS: 7421
PathwayNCI Pathway Interaction Database: VDR
KEGG: VDR
REACTOME: VDR
Pathway Commons: VDR
ContextiHOP: VDR
ligand binding site mutation search in PubMed: VDR
UCL Cancer Institute: VDR
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for VDR.1. "Papadopoulou A, Bountouvi E, Gole E, Doulgeraki A, Tournis S, Papadimitriou A, Nicolaidou P. Identification of a novel nonsense mutation in the ligand-binding domain of the vitamin d receptor gene and clinical description of two greek patients with hereditary vitamin d-resistant rickets and alopecia. Horm Res Paediatr. 2014;82(3):206-12. doi: 10.1159/000362618. Epub 2014 Jul 23." 25060608
2. "Yaghmaei S, Roberts C, Ai R, Mizwicki MT, Chang CE. Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications. In Silico Pharmacol. 2013 Feb 12;1:2. doi:10.1186/2193-9616-1-2. eCollection 2013." 25505647
3. "Futawaka K, Tagami T, Fukuda Y, Koyama R, Nushida A, Nezu S, Yamamoto H, Imamoto M, Kasahara M, Moriyama K. Transcriptional activation of the wild-type and mutant vitamin D receptors by vitamin D3. J Mol Endocrinol. 2016 May 6. pii: JME-16-0048." 27154546

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0000122negative regulation of transcription from RNA polymerase II promoter17426122
GO:0008285negative regulation of cell proliferation16549446
GO:0010980positive regulation of vitamin D 24-hydroxylase activity16549446
GO:0038183bile acid signaling pathway12016314
GO:0045892negative regulation of transcription, DNA-templated11891224
GO:0070561vitamin D receptor signaling pathway16549446


Top
Ligand binding site mutations for VDR
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R74R74HUCEC2
V300D299ECOAD1
L414T415AHNSC1
C27G28AKIRC1
Y295K294MLUAD1
H397,Y401K399MLUSC1
F150D149YOV1
A231A231VSKCM1
S278F279LSKCM1
I268A267VSTAD1
F47F47YSTAD1
R274R274CTHCA1
F34G33DUCEC1
F422,V418E420KUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for VDR
Protein structure of wild type (WT) and mutant type (MT) of VDR
Wild type VDR
Mutant type VDR

Free energy of binding of drugs to wild type and mutant tpye of VDR
Gene symbolDrug nameFree energy of binding (kcal/mol) of wild typeFree energy of binding (kcal/mol) of mutant type
VDRCalcidiol-7.7-7.9
VDRCalcipotriol-8.5-8.5

Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R74R74H-1.4793518
F47F47Y-1.2128435
Y295K294M-1.1266264
V418E420K-1.0958124
F422E420K-1.0958124
L414T415A-0.84869982
R274R274C-0.81537371
S278F279L-0.47664603
I268A267V-0.44992448
C27G28A-0.4192122
A231A231V-0.41031066
F150D149Y-0.3821139
H397K399M-0.15915047
Y401K399M-0.15915047
F34G33D-0.12455876
V300D299E-0.000808632
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for VDR from PDB
PDB IDPDB titlePDB structure
3WGPCrystal Structure Analysis of Vitamin D receptor

Top
Differential gene expression and gene-gene network for VDR
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of VDR and the right PPI network was created from samples without mutations in the LBS of VDR. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for VDR
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0029456Osteoporosis76Biomarker, GeneticVariation
umls:C0035579Rickets24Biomarker, GeneticVariation
umls:C0033578Prostatic Neoplasms18AlteredExpression, Biomarker, GeneticVariation
umls:C0042870Vitamin D Deficiency15Biomarker, GeneticVariation
umls:C0342646Vitamin D-Dependent Rickets, Type 2A9Biomarker, GeneticVariation
umls:C0020538Hypertension6Biomarker, GeneticVariation
umls:C0027651Neoplasms5Biomarker, GeneticVariation
umls:C0002170Alopecia4Biomarker, GeneticVariation
umls:C0041948Uremia3Biomarker, GeneticVariation
umls:C0268690Rickets, Hereditary Vitamin D-Resistant3Biomarker, GeneticVariation
umls:C0007138Carcinoma, Transitional Cell1Biomarker
umls:C0014556Epilepsy, Temporal Lobe1Biomarker
umls:C0950123Genetic Diseases, Inborn1Biomarker
umls:C0023434Leukemia, Lymphocytic, Chronic, B-Cell1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs
22784G33DPathogenicGermlineMedGen:C0268690
OMIM:277440
Orphanet:ORPHA93160
SNOMED CT:72831007

Top
Pharmacological information for VDR
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|nutraceuticalDB00136CalcitriolSmall molecule
Approved|nutraceuticalDB00146CalcidiolSmall molecule
Approved|nutraceuticalDB00153ErgocalciferolSmall molecule
Approved|nutraceuticalDB00169CholecalciferolSmall molecule
Approved|investigationalDB00910ParicalcitolSmall molecule
ApprovedDB01070DihydrotachysterolSmall molecule
Approved|nutraceuticalDB01436AlfacalcidolSmall molecule
ApprovedDB02300CalcipotriolSmall molecule
ExperimentalDB034511-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3Small molecule
ExperimentalDB04258SeocalcitolSmall molecule
ExperimentalDB04796InecalcitolSmall molecule
InvestigationalDB05024CTA018Small molecule
InvestigationalDB05295EldecalcitolSmall molecule
ApprovedDB06410DoxercalciferolSmall molecule
ExperimentalDB07530(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diolSmall molecule
ExperimentalDB086965-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOLSmall molecule
ExperimentalDB087421,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)Small molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of VDR go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
TEJ(23S)-25-DEHYDRO-1ALPHA-HYDROXYVITAMIN D3-26,23-LACTONE3a2jAA231 R274 S278 V300
KH11ALPHA,25-DIHYDROXYL-20-EPI-22-OXA-24,26,27-TRIHOMOVITAMIN D31ie8AA231 R274 S278 V300 H397
ZNE(1R,3S,5Z)-5-[(2E)-2-{(1R,3AS,7AR)-1-[(1R,5S)-5-HYDROXY-1-METHYL-5-(1,3-THIAZOL-2-YL)PENTYL]-7A-METHYLOCTAHYDRO-4H-INDEN-4-YLIDENE}ETHYLIDENE]-4-METHYLIDENECYCLOHEXANE-1,3-DIOL3kpzAA231 R274 S278 Y295 H397 Y401 L414 V418
EB1SEOCALCITOL1s0zAA231 R274 S278 Y295 V300 H397 L414 F422
6DS(4S)-4-HYDROXY-5-[2-METHYL-4-(3-{3-METHYL-4-[(1E)-4,4, 4-TRIFLUORO-3-HYDROXY-3-(TRIFLUOROMETHYL)BUT-1-EN-1- YL]PHENYL}PENTAN-3-YL)PHENOXY]PENTANOIC ACID3w0cAA231 R274 Y295 V300 H397 Y401 L414 V418 F422
ZNZINC(2+)1kb2AC27
ZNZINC(2+)1kb4AC27
ZNZINC(2+)1kb6AC27
ZNZINC(2+)1ynwAC27
VHWMETHYL (1S,3E)-3-{(2R)-2-[(1R,3AS,4E,7AR)-4-{(2Z)-2- [(3R,4S,5R)-3,5-DIHYDROXY-4-(3-HYDROXYPROPOXY)-2- METHYLIDENECYCLOHEXYLIDENE]ETHYLIDENE}-7A- METHYLOCTAHYDRO-1H-INDEN-1-YL]PROPYLIDENE}-1-ETHYL-2- OXOCYCLOPENTANECARBOXYLATE (NON-PREFERRED NAME)3vhwAF150 A231 I268 R274 S278 V300 H397 V418 F422
DS4[3-FLUORO-2'-METHYL-4'-(3-{3-METHYL-4-[(1E)-4,4,4- TRIFLUORO-3-HYDROXY-3-(TRIFLUOROMETHYL)BUT-1-EN-1- YL]PHENYL}PENTAN-3-YL)BIPHENYL-4-YL]ACETIC ACID3w0yAF150 A231 I268 R274 Y295 H397 Y401 L414 V418 F422
TEJ(23S)-25-DEHYDRO-1ALPHA-HYDROXYVITAMIN D3-26,23-LACTONE3a2iAF150 A231 R274 S278 V300 H397
DS2{4-[3-(4-{[(2R)-2-HYDROXY-3,3-DIMETHYLBUTYL]OXY}-3-METHYLPHENYL)PENTAN-3-YL]-2-METHYLPHENOXY}ACETIC ACID3az1AF150 A231 R274 S278 Y295 V300 H397 Y401 F422
DS35-{4-[3-(4-{[(2R)-2-HYDROXY-3,3-DIMETHYLBUTYL]OXY}-3-METHYLPHENYL)PENTAN-3-YL]-2-METHYLPHENOXY}PENTANOICACID3az2AF150 A231 R274 S278 Y295 V300 H397 Y401 L414 F422
DS6(4S)-4-HYDROXY-5-[4-(3-{4-[(3S)-3-HYDROXY-4,4-DIMETHYLPENTYL]-3-METHYLPHENYL}PENTAN-3-YL)-2-METHYLPHENOXY]PENTANOIC ACID3az3AF150 A231 R274 V300 Y401 L414 F422
DS5(4S)-4-HYDROXY-5-[2-METHYL-4-(3-{3-METHYL-4-[4,4,4- TRIFLUORO-3-HYDROXY-3-(TRIFLUOROMETHYL)BUT-1-YN-1- YL]PHENYL}PENTAN-3-YL)PHENOXY]PENTANOIC ACID3w0aAF150 A231 R274 Y295 V300 H397 Y401 L414 V418 F422
CA9(1R,2S,3R)-5-[2-[(1R,3AS,7AR)-1-[(2R)-6-HYDROXY-6-METHYL-HEPTAN-2-YL]-7A-METHYL-1,2,3,3A,6,7-HEXAHYDROINDEN-4-YL]ETHYNYL]-2-METHYL-CYCLOHEX-4-ENE-1,3-DIOL3auqAF150 I268 R274 S278 V300 H397 V418
2MV(1S,2S,3R,5Z,7E,14BETA,17ALPHA)-17-[(2S,4S)-4-(2-HYDROXY-2-METHYLPROPYL)-2-METHYLTETRAHYDROFURAN-2-YL]-2-METHYL-9,10-SECOANDROSTA-5,7,10-TRIENE-1,3-DIOL3a3zXF150 R274 S278 H397
MVD9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-METHYL-,(1A,2A,3B,5Z,7E)2hb8AF150 R274 S278 V300 H397
CA9(1R,2S,3R)-5-[2-[(1R,3AS,7AR)-1-[(2R)-6-HYDROXY-6-METHYL-HEPTAN-2-YL]-7A-METHYL-1,2,3,3A,6,7-HEXAHYDROINDEN-4-YL]ETHYNYL]-2-METHYL-CYCLOHEX-4-ENE-1,3-DIOL3aurAF150 R274 S278 V300 H397
OCC9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-(3-HYDROXYPROPOXY)-,(1A,2A,3B,5Z,7E)2harAF150 R274 S278 V300 H397 V418
C3O9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-PROPOXY-,(1A,2A,3B,5Z,7E)2hasAF150 R274 S278 V300 H397 V418
TEY(1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1- [(2R)-6-METHYL-6-OXIDANYL-HEPTAN-2-YL]-2,3,3A,5,6,7- HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4- METHYLIDENE-2-[2-(1,2,3,4-TETRAZOL-2-YL) ETHYL]CYCLOHEXANE-1,3-DIOL4iteAF150 R274 S278 V300 H397 V418
2KB4-{[(1R,2S,3R,5Z,7E,14BETA,17ALPHA)-1,3,25-TRIHYDROXY- 9,10-SECOCHOLESTA-5,7,10-TRIEN-2-YL]OXY}BUTANENITRILE4pa2AF150 R274 S278 V300 H397 Y401
23R(1S,2S,3R,5Z,7E,14BETA,17ALPHA,23R)-23-(2-HYDROXY-2-METHYLPROPYL)-2-METHYL-20,24-EPOXY-9,10-SECOCHOLA-5,7,10-TRIENE-1,3-DIOL3a40XF150 R274 S278 Y295 V300 H397
C339,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-PROPYL-,(1A,2A,3B,5Z,7E)2hamAF150 R274 S278 Y295 V300 H397 V418
O1C9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-(3-HYDROXYPROPYL)-,(1A,2A,3B,5Z,7E)2hb7AF150 R274 S278 Y295 V300 H397 V418
NUCNucleic Acids1kb2AF34
NUCNucleic Acids1kb4AF34
NUCNucleic Acids1kb6AF34
NUCNucleic Acids1ynwAF34
NUCNucleic Acids1ynwAF47
NUCNucleic Acids1kb2AF47 R74
NUCNucleic Acids1kb4AF47 R74
NUCNucleic Acids1kb6AF47 R74
FMV(1S,3R,5Z,7E,14BETA,17ALPHA,20S)-20-[5-(1-HYDROXY-1-METHYLETHYL)FURAN-2-YL]-9,10-SECOPREGNA-5,7,10-TRIENE-1,3-DIOL3ogtAI268 R274 S278 V300 H397
FMV(1S,3R,5Z,7E,14BETA,17ALPHA,20S)-20-[5-(1-HYDROXY-1-METHYLETHYL)FURAN-2-YL]-9,10-SECOPREGNA-5,7,10-TRIENE-1,3-DIOL3tkcAI268 R274 S278 V300 H397
TX5TX5221txiAI268 R274 S278 Y295 V300 H397
NUCNucleic Acids1kb4BR274
NUCNucleic Acids1kb6BR274
VDXCALCITRIOL1db1AR274 S278 H397
3AJ1-({[(1R,2S,3R,5Z,7E,14BETA,17ALPHA)-1,3,25-TRIHYDROXY- 9,10-SECOCHOLESTA-5,7,10-TRIEN-2-YL]OXY}METHYL) CYCLOPROPANECARBONITRILE3wwrAR274 S278 H397
VDXCALCITRIOL1ie9AR274 S278 V300 H397
3EV1ALPHA,25-DIHYDROXY-3-EPI-VITAMIN D33a78AR274 S278 V300 H397
MCZMAXACALCITOL3b0tAR274 S278 V300 H397
COV(1S,3R,5Z,7E,14BETA,17ALPHA)-17-[(2S,4S)-4-(2-HYDROXY-2-METHYLPROPYL)-2-METHYLTETRAHYDROFURAN-2-YL]-9,10-SECOANDROSTA-5,7,10-TRIENE-1,3-DIOL3cs4AR274 S278 V300 H397
41V(1R,3R,7Z,14BETA,17ALPHA)-17-[(2R)-6-HYDROXY-6- METHYLHEPTAN-2-YL]-9,10-SECOESTRA-5,7-DIENE-1,3-DIOL3x31AR274 S278 V300 H397
ZYD(1R,3S,5Z)-5-{(2E)-2-[(3AR,7AS)-7A-(7-HYDROXY-7-METHYLOCTYL)OCTAHYDRO-4H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXANE-1,3-DIOL3p8xAR274 S278 V300 H397 L414 V418 F422
EIM(1R,3S,5Z)-5-[(2E)-2-[(1R,3S,3AS,7AR)-1-[(2R)-6-HYDROXY-6-METHYL-HEPTAN-2-YL]-3-METHOXY-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXANE-1,3-DIOL3ax8AR274 S278 V300 H397 V418
VDXCALCITRIOL3m7rAR274 S278 V300 H397 V418
TFY(1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1- [(2R)-6-METHYL-6-OXIDANYL-HEPTAN-2-YL]-2,3,3A,5,6,7- HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4- METHYLIDENE-2-[2-(1,2,3,4-TETRAZOL-1-YL) ETHYL]CYCLOHEXANE-1,3-DIOL4itfAR274 S278 V300 H397 V418
ED9(1R,2R,3R,5Z,7E,14BETA,17ALPHA)-2-(3-HYDROXYPROPOXY)-9, 10-SECOCHOLESTA-5,7,10-TRIENE-1,3,25-TRIOL3wgpAR274 S278 V300 H397 V418
0VQ(3E,5E)-6-(3-{2-[3,4-BIS(HYDROXYMETHYL) PHENYL]ETHYL}PHENYL)-1,1,1-TRIFLUORO-2- (TRIFLUOROMETHYL)OCTA-3,5-DIEN-2-OL4g2iAR274 S278 V300 H397 Y401 V418 F422
0CO(1S,3R,5Z,7E,14BETA,17ALPHA,23R)-23-(2-HYDROXY-2-METHYLPROPYL)-20,24-EPOXY-9,10-SECOCHOLA-5,7,10-TRIENE-1,3-DIOL3cs6AR274 S278 Y295 H397
MC9CALCIPOTRIOL1s19AR274 S278 Y295 V300 H397
NUCNucleic Acids1kb4BV300
NUCNucleic Acids1kb6BV300


Top
Conservation information for LBS of VDR
Multiple alignments for P11473 in multiple species
LBSAA sequence# speciesSpecies
A231MLPHLADLVSY7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
A303NDVTKAGHTLE2Danio rerio, Danio rerio
A303SDVTKAGHSLE1Homo sapiens
A303SDVTQAGHSMD1Gallus gallus
A303TDVSRAGHTLE1Mus musculus
A303TDVSKAGHTLE1Rattus norvegicus
A303SDVTRAGHSLE1Bos taurus
C24NVPRICGVCGD6Homo sapiens, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
C24NAPRICGVCGD1Danio rerio
C27RICGVCGDRAT5Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
C27RICGVCGDKAT2Danio rerio, Danio rerio
C288DMSWDCGSQDY2Mus musculus, Rattus norvegicus
C288DMSWTCGNQDY1Homo sapiens
C288DMSWSCGGPDF1Danio rerio
C288DMSWSCGGPEF1Danio rerio
C288DMSWTCGSNDF1Gallus gallus
C288DMSWTCGSPDY1Bos taurus
C41FNAMTCEGCKG7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
C44MTCEGCKGFFR7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
D144HHKTYDDSYSD2Danio rerio, Danio rerio
D144HHKTYDPTYAD2Mus musculus, Rattus norvegicus
D144HHKTYDPTYSD1Homo sapiens
D144HHKTFDTTYSD1Gallus gallus
D144HHKTYDDTYSD1Bos taurus
E42NAMTCEGCKGF7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
F150PTYADFRDFRP2Mus musculus, Rattus norvegicus
F150PTYSDFCQFRP1Homo sapiens
F150DSYSDFVRFRP1Danio rerio
F150DSYSDFSRFRP1Danio rerio
F150TTYSDFNKFRP1Gallus gallus
F150DTYSDFSQFRP1Bos taurus
F34DRATGFHFNAM5Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
F34DKATGFHFNAM2Danio rerio, Danio rerio
F36ATGFHFNAMTC7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
F422LVLEVFGNEIS4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
F422LVLEVFGSEVS1Danio rerio
F422LVLEVFGGQVT1Danio rerio
F422LLFEVFGNEIS1Bos taurus
F47EGCKGFFRRSM7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
F93GMMKEFILTDE7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
G43AMTCEGCKGFF7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
H305VTKAGHTLELL2Danio rerio, Danio rerio
H305VTKAGHSLELI1Homo sapiens
H305VTQAGHSMDLL1Gallus gallus
H305VSRAGHTLELI1Mus musculus
H305VSKAGHTLELI1Rattus norvegicus
H305VTRAGHSLELI1Bos taurus
H35RATGFHFNAMT5Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
H35KATGFHFNAMT2Danio rerio, Danio rerio
H397SLNEEHSKQYR7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
H75KDNRRHCQACR7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
I107RKREMILKRKE3Homo sapiens, Gallus gallus, Bos taurus
I107RKREMIMKRKE2Mus musculus, Rattus norvegicus
I107RKKDLIMKRKE1Danio rerio
I107RKKELIQRRKD1Danio rerio
I268LKSSAIEVIML6Homo sapiens, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
I268LKSSAIEIIML1Danio rerio
I271SAIEVIMLRSN6Homo sapiens, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
I271SAIEIIMLRSN1Danio rerio
I94MMKEFILTDEE7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
K240SYSIQKVIGFA7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
K45TCEGCKGFFRR7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
L227SQLSMLPHLAD2Homo sapiens, Bos taurus
L227SPLSMLPHLAD2Mus musculus, Rattus norvegicus
L227SRLSMLPHLAD1Danio rerio
L227SSLSMLPHLAD1Danio rerio
L227PHLPMLPHLAD1Gallus gallus
L230SMLPHLADLVS6Homo sapiens, Danio rerio, Danio rerio, Mus musculus, Rattus norvegicus, Bos taurus
L230PMLPHLADLVS1Gallus gallus
L233PHLADLVSYSI7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
L309GHSLELIEPLI2Homo sapiens, Bos taurus
L309GHTLELLEPLV2Danio rerio, Danio rerio
L309GHTLELIEPLI2Mus musculus, Rattus norvegicus
L309GHSMDLLEPLV1Gallus gallus
L313ELIEPLIKFQV4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
L313ELLEPLVKFQV2Danio rerio, Danio rerio
L313DLLEPLVKFQV1Gallus gallus
L404KQYRSLSFQPE4Danio rerio, Danio rerio, Mus musculus, Rattus norvegicus
L404KQYRCLSFQPE3Homo sapiens, Gallus gallus, Bos taurus
L414EHSMQLTPLVL3Danio rerio, Danio rerio, Gallus gallus
L414ENSMKLTPLVL2Mus musculus, Rattus norvegicus
L414ECSMKLTPLVL1Homo sapiens
L414ESSMKLTPLLF1Bos taurus
L95MKEFILTDEEV7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
M272AIEVIMLRSNQ5Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
M272AIEVIMLRSNE1Homo sapiens
M272AIEIIMLRSNQ1Danio rerio
Q77NRRHCQACRLK7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R104EVQRKREMILK3Homo sapiens, Gallus gallus, Bos taurus
R104EVQRKREMIMK2Mus musculus, Rattus norvegicus
R104EVQRKKDLIMK1Danio rerio
R104EVQRKKELIQR1Danio rerio
R274EVIMLRSNQSF5Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R274EVIMLRSNESF1Homo sapiens
R274EIIMLRSNQSF1Danio rerio
R49CKGFFRRSMKR7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R50KGFFRRSMKRK7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R54RRSMKRKALFT4Homo sapiens, Mus musculus, Rattus norvegicus, Bos taurus
R54RRSMKRKASFT2Danio rerio, Danio rerio
R54RRSMKRKAMFT1Gallus gallus
R73ITKDNRRHCQA7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R74TKDNRRHCQAC7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
R80HCQACRLKRCV4Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus
R80HCQACRLKRCI2Danio rerio, Bos taurus
R80HCQACRLKRCL1Danio rerio
S237DLVSYSIQKVI7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
S275VIMLRSNQSFT4Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
S275VIMLRSNESFT1Homo sapiens
S275IIMLRSNQSFS1Danio rerio
S275VIMLRSNQSFS1Danio rerio
S278LRSNQSFSL-E2Danio rerio, Danio rerio
S278LRSNESFTM-D1Homo sapiens
S278LRSNQSFTM-E1Gallus gallus
S278LRSNQSFTL-D1Mus musculus
S278LRSNQSFTM-D1Rattus norvegicus
S278LRSNQSFTLDD1Bos taurus
T142DAHHKTYDPTY3Homo sapiens, Mus musculus, Rattus norvegicus
T142EAHHKTYDDSY1Danio rerio
T142DAHHKTYDDSY1Danio rerio
T142EAHHKTFDTTY1Gallus gallus
T142EAHHKTYDDTY1Bos taurus
V100LTDEEVQRKRE5Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
V100LTDEEVQRKKD1Danio rerio
V100LTDEEVQRKKE1Danio rerio
V234HLADLVSYSIQ7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
V300YRVSDVTKAGH1Homo sapiens
V300YCINDVTKAGH1Danio rerio
V300YCVNDVTKAGH1Danio rerio
V300YKVSDVTQAGH1Gallus gallus
V300YDITDVSRAGH1Mus musculus
V300YDVTDVSKAGH1Rattus norvegicus
V300YQVSDVTRAGH1Bos taurus
V418KLTPLVLEVFG3Homo sapiens, Mus musculus, Rattus norvegicus
V418QLTPLVLEVFG3Danio rerio, Danio rerio, Gallus gallus
V418KLTPLLFEVFG1Bos taurus
W286-EDMSWSCGGP2Danio rerio, Danio rerio
W286-DDMSWDCGSQ2Mus musculus, Rattus norvegicus
W286-DDMSWTCGNQ1Homo sapiens
W286-EDMSWTCGSN1Gallus gallus
W286DDDMSWTCGSP1Bos taurus
Y143AHHKTYDDSYS2Danio rerio, Danio rerio
Y143AHHKTYDPTYA2Mus musculus, Rattus norvegicus
Y143AHHKTYDPTYS1Homo sapiens
Y143AHHKTFDTTYS1Gallus gallus
Y143AHHKTYDDTYS1Bos taurus
Y147TYDPTYADFRD2Mus musculus, Rattus norvegicus
Y147TYDPTYSDFCQ1Homo sapiens
Y147TYDDSYSDFVR1Danio rerio
Y147TYDDSYSDFSR1Danio rerio
Y147TFDTTYSDFNK1Gallus gallus
Y147TYDDTYSDFSQ1Bos taurus
Y236ADLVSYSIQKV7Homo sapiens, Danio rerio, Danio rerio, Gallus gallus, Mus musculus, Rattus norvegicus, Bos taurus
Y295NQDYKYRVSDV1Homo sapiens
Y295GPDFKYCINDV1Danio rerio
Y295GPEFKYCVNDV1Danio rerio
Y295SNDFKYKVSDV1Gallus gallus
Y295SQDYKYDITDV1Mus musculus
Y295SQDYKYDVTDV1Rattus norvegicus
Y295SPDYKYQVSDV1Bos taurus
Y401EHSKQYRSLSF4Danio rerio, Danio rerio, Mus musculus, Rattus norvegicus
Y401EHSKQYRCLSF3Homo sapiens, Gallus gallus, Bos taurus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas